Shuichi Furuya

Discovery of a Thieno[2,3- <i>d</i> ]pyrimidine-2,4-dione Bearing a <i>p</i> -Methoxyureidophenyl Moiety at the 6-Position:  A Highly Potent and Orally Bioavailable Non-Peptide Antagonist for the Human Luteinizing Hormone-Releasing Hormone Receptor

Satoshi Sasaki, Nobuo Cho, Yoshi Nara et al. · Journal of Medicinal Chemistry · 2002 · 161 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Discovery of a Novel, Potent, and Orally Active Nonpeptide Antagonist of the Human Luteinizing Hormone-Releasing Hormone (LHRH) Receptor

Nobuo Cho, Masataka Harada, Toshihiro Imaeda et al. · Journal of Medicinal Chemistry · 1998 · 126 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer

Tomohiro Kaku, Takenori Hitaka, Akio Ojida et al. · Bioorganic & Medicinal Chemistry · 2011 · 126 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

Discovery of 1-{4-[1-(2,6-Difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3- <i>d</i> ]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a Potent, Orally Active, Non-Peptide Antagonist of the Human Gonadotropin-Releasing Hormone Receptor

Kazuhiro Miwa, Takenori Hitaka, Takashi Imada et al. · Journal of Medicinal Chemistry · 2011 · 100 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Self-assembling A6K peptide nanotubes as a mercaptoundecahydrododecaborate (BSH) delivery system for boron neutron capture therapy (BNCT)

Hiroyuki Michiue, Mizuki Kitamatsu, Asami Fukunaga et al. · Journal of Controlled Release · 2020 · 43 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17